Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07213427
What this trial is testing

Outcomes of Image-guided High-dose-rate Uterovaginal Brachytherapy With Single Implantation

Who this might be right for
LOCALLY ADVANCED CERVICAL CANCERS
Assistance Publique - Hôpitaux de Paris 363
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07249892
What this trial is testing

BPR-6023021 in Advanced Solid Tumors With Bone Metastases

Who this might be right for
Metastatic Solid Tumors
Chengdu Syncor Pharmaceutical Co., Ltd. 195
Testing effectiveness (Phase 2)Study completedNCT03939689
What this trial is testing

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerProstatic Neoplasm+2 more
Progenics Pharmaceuticals, Inc. 120
Very early researchLooking for participantsNCT07689643
What this trial is testing

Safety and Preliminary Efficacy of [177Lu]Lu-RTX-2358 Combined With Immune Checkpoint Inhibitors in Patients With FAP-positive Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Early research (Phase 1)Study completedNCT05974579
What this trial is testing

Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Université de Sherbrooke 8
Not applicableLooking for participantsNCT07670949
What this trial is testing

Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies

Who this might be right for
Hematological Malignancies B
Zhejiang Cancer Hospital 30
Early research (Phase 1)Active Not RecruitingNCT06337084
What this trial is testing

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultBladder CancerUrothelial Carcinoma+6 more
Monopar Therapeutics 12
Not applicableUnknownNCT05613738
What this trial is testing

177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital 9
Early research (Phase 1)Study completedNCT06840535
What this trial is testing

Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic DiseasePSA Level Greater Than 0.2
Philogen S.p.A. 20
Large-scale testing (Phase 3)Looking for participantsNCT07373782
What this trial is testing

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Universitaire Ziekenhuizen KU Leuven 53
Very early researchLooking for participantsNCT07542379
What this trial is testing

The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd. 13
Early research (Phase 1)Looking for participantsNCT07006727
What this trial is testing

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaLarge Cell Neuroendocrine Carcinoma of the LungNeuroendocrine Prostate Cancer+8 more
Novartis Pharmaceuticals 116
Not applicableLooking for participantsNCT07767500
What this trial is testing

Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer

Who this might be right for
Primary Renal Cancer
NYU Langone Health 30
Early research (Phase 1)Looking for participantsNCT07261631
What this trial is testing

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerHR+/HER2- Ductal and Lobular Breast Cancer+3 more
Novartis Pharmaceuticals 180
Early research (Phase 1)Study completedNCT05241522
What this trial is testing

Dosimetry of Tc-99m-Tilmanocept

Who this might be right for
Diabetic Kidney Disease
University of California, San Diego 57
Very early researchLooking for participantsNCT06734572
What this trial is testing

18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study

Who this might be right for
Malignant Neoplasm
First Affiliated Hospital of Fujian Medical University 5
Early research (Phase 1)Study completedNCT00413647
What this trial is testing

A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Fluoropharma, Inc. 21
Early research (Phase 1)Study completedNCT05861778
What this trial is testing

Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSuspected Recurrent Renal Clear Cell CarcinomaRecurrent Renal Cell Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 10
Early research (Phase 1)UnknownNCT03142204
What this trial is testing

[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy

Who this might be right for
Cancer
CellSight Technologies, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01456078
What this trial is testing

Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsLiver Metastases
Lund University Hospital 60
Next Page